Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study
Open Access
- 2 June 2016
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 16 (1) , 1-9
Abstract
To describe common type 2 diabetes treatment intensification regimens, patients’ characteristics and changes in glycated hemoglobin (HbA1c) and body mass index (BMI). We constructed a national retrospective cohort of veterans initially treated for diabetes with either metformin or sulfonylurea from 2001 through 2008, using Veterans Health Administration (VHA) and Medicare data. Patients were followed through September, 2011 to identify common diabetes treatment intensification regimens. We evaluated changes in HbA1c and BMI post-intensification for metformin-based regimens. We identified 323,857 veterans who initiated diabetes treatment. Of these, 55 % initiated metformin, 43 % sulfonylurea and 2 % other regimens. Fifty percent (N = 89,057) of metformin initiators remained on metformin monotherapy over a median follow-up 58 months (interquartile range [IQR] 35, 74). Among 80,725 patients who intensified metformin monotherapy, the four most common regimens were addition of sulfonylurea (79 %), thiazolidinedione [TZD] (6 %), or insulin (8 %), and switch to insulin monotherapy (2 %). Across these regimens, median HbA1c values declined from a range of 7.0–7.8 % (53–62 mmol/mol) at intensification to 6.6–7.0 % (49–53 mmol/mol) at 1 year, and remained stable up to 3 years afterwards. Median BMI ranged between 30.5 and 32 kg/m2 at intensification and increased very modestly in those who intensified with oral regimens, but 1–2 kg/m2 over 3 years among those who intensified with insulin-based regimens. By 1 year post-intensification of metformin monotherapy, HbA1c declined in all four common intensification regimens, and remained close to 7 % in subsequent follow-up. BMI increased substantially for those on insulin-based regimens.Keywords
Funding Information
- VA Clinical Science Research and Development (CX000570-01)
- Center for Diabetes Translation Research (P30DK092986)
- VA Career Development (2-031-09S)
This publication has 27 references indexed in Scilit:
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Comparative effectiveness of incident oral antidiabetic drugs on kidney functionKidney International, 2012
- Drug titration patterns and HbA1clevels in type 2 diabetesInternational Journal Of Clinical Practice, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Executive Summary: Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Changing Incident Diabetes RegimensDiabetes Care, 2007
- Veterans’ Access to and Use of Medicare and Veterans Affairs Health CareMedical Care, 2007
- Evaluating Medication Effects Outside of Clinical Trials: New-User DesignsAmerican Journal of Epidemiology, 2003
- A new distribution-free quantile estimatorBiometrika, 1982